| Literature DB >> 33209691 |
Dechao Feng1, Yin Tang1, Yubo Yang1, Xin Wei1, Ping Han1, Wuran Wei1.
Abstract
Our aim is to assess the efficacy of prophylactic ureteral catheter placement on patients undergoing laparoscopic gynecological surgery. We searched the electronic database including PubMed, Cochrane Library, Embase, Web of Science, WANFANG and CNKI in January 2020 to identify possible studies without languages limitations. A manual search was also conducted. The trials that compared catheterized group (CG) to non-catheterized group (NCG) were included. This meta-analysis was accomplished by RevMan5 (version 5.3). Initial search yield 997 studies and 5 randomized control trials were included in the final meta-analysis. Pooling data of five studies showed that patients in the CG had a lower risk of ureteral injury than those in NCG (RR: 0.44, 95% CI: 0.20-0.97, P=0.04) without significant between-study heterogeneity (P=0.23, I2=29%). The pooled data analysis showed a statistically significant difference in favor of prophylactic ureter catheter placement (MD: -40.51, 95% CI: -58.65 to -22.36, P<0.0001). Random-effects model meta-analysis found that patients in the CG experienced higher EBL compared to NCG (SMD: -5.78, 95% CI: -10.51 to -1.04, P=0.02). There was no statistically significant difference between CG group and NCG group (P=0.23) with regard to LOS. Current evidence indicates that prophylactic ureteral catheter placement has the advantages of reducing ureteral injury, shortening the operative time, and reducing the amount of bleeding. It might serve as a routine preoperative preparation choice for laparoscopic gynecological surgery, especially with pelvic adhesion. Further large volume, multicenter well-designed trials are warranted before making the final clinical guidelines. 2020 Translational Andrology and Urology. All rights reserved.Entities:
Keywords: Ureteral catheter; double-J stent; gynecological surgery; iatrogenic ureteral injury; randomized control trial (RCT); ureteral stent
Year: 2020 PMID: 33209691 PMCID: PMC7658113 DOI: 10.21037/tau-20-674
Source DB: PubMed Journal: Transl Androl Urol ISSN: 2223-4683
Figure 1The risk of bias summary of included studies.
Figure 2The flow chart of the study selection.
The baseline characteristics of included studies
| Study ID | Country | Language | Duration | Populations | Sample size (CG/NCG) | Age, tears (CG/NCG) | Outcomes& | LoE |
|---|---|---|---|---|---|---|---|---|
| Chou, 2009 | China | English | 1996.1 to 2007.12 | Inclusion: laparoscopic hysterectomy; oophorectomy. Exclusion: without consent form; operative time less than 30 min; follow-up less than 6 months | 527/472 | 41.79±12.43/ | 1 | 1b |
| Han, 2009 | China | Chinese | 2006.1 to 2008.8 | Inclusion: pelvic adhesions; laparoscopic hysterectomy | 15/12 | Similar group | 1, 2 | 2b |
| Li, 2017 | China | Chinese | 2012.5 to 2014.5 | Inclusion: radical hysterectomy; myomectomy; ovarian cyst ablation | 42/42 | 42.5±3.4/43.5±3.6 | 1, 2, 3 | 2b |
| Wei, 2015 | China | Chinese | 2013.1 to 2015.1 | Inclusion: laparoscopic hysterectomy; oophorectomy | 60/60 | Similar group | 1, 2, 3, 4 | 2b |
| Zhang, 2017 | China | English | 2009.6 to 2014.12 | Inclusion: cervical cancer (22 stage I and 13 stage II cases, based on IFGO), 23 cases of ovarian cancer (12 stage I and 11 stage II cases), and 3 cases with multiple myomata | 32/28 | Similar group | 1, 2, 3, 4 | 2b |
&, 1: ureteral injury; 2: operative time; 3: estimated blood loss; 4: length of stay. IFGO, International Federation of Gynaecology and Obstetrics criteria; LoE, level of evidence; CG, catheterization group; NCG, non-catheterization group.
Figure 3The outcomes of this meta-analysis.